Advances in copper complexes as anticancer agents

C Santini, M Pellei, V Gandin, M Porchia… - Chemical …, 2014 - ACS Publications
Medicinal inorganic chemistry offers additional opportunities for the design of therapeutic
agents not accessible to organic compounds. 1− 3 The wide range of coordination numbers …

Recent advances in cancer therapeutic copper-based nanomaterials for antitumor therapy

R Aishajiang, Z Liu, T Wang, L Zhou, D Yu - Molecules, 2023 - mdpi.com
Copper serves as a vital microelement which is widely present in the biosystem, functioning
as multi-enzyme active site, including oxidative stress, lipid oxidation and energy …

Copper in diseases and treatments, and copper‐based anticancer strategies

F Tisato, C Marzano, M Porchia… - Medicinal research …, 2010 - Wiley Online Library
Copper is found in all living organisms and is a crucial trace element in redox chemistry,
growth and development. It is important for the function of several enzymes and proteins …

Copper complexes as anticancer agents

C Marzano, M Pellei, F Tisato… - Anti-Cancer Agents in …, 2009 - ingentaconnect.com
Metal-based antitumor drugs play a relevant role in antiblastic chemotherapy. Cisplatin is
regarded as one of the most effective drugs, even if severe toxicities and drug resistance …

Advances in metal–carbene complexes as potent anti-cancer agents

A Gautier, F Cisnetti - Metallomics, 2012 - academic.oup.com
This critical review is an updated survey of metal–carbenes as potential anticancer
chemotherapeutics. We report on the recent advances in the discovery of N-heterocyclic …

Copper compounds in anticancer strategies

S Tardito, L Marchio - Current medicinal chemistry, 2009 - ingentaconnect.com
The chemical properties of copper allow it to take part in many biological functions such as
electron transfer, catalysis, and structural sha**. The ability to cycle between+ 1 and+ 2 …

Metal-NHC complexes: a survey of anti-cancer properties

ML Teyssot, AS Jarrousse, M Manin, A Chevry… - Dalton …, 2009 - pubs.rsc.org
New weapons to fight cancer are constantly needed. Among chemotherapeutics, anti-cancer
metal-drugs have enjoyed a long and successful history since the discovery of the …

Designing anticancer copper (II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands

J Deng, P Yu, Z Zhang, J Wang, J Cai, N Wu… - European Journal of …, 2018 - Elsevier
To develop potential next-generation metal anticancer agents, we designed and
synthesised five Cu (II) 2-pyridine-thiosemicarbazone complexes by modifying the hydrogen …

A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling

V Gandin, M Pellei, F Tisato, M Porchia… - Journal of cellular …, 2012 - Wiley Online Library
Platinum anticancer drugs have been used for three decades despite their serious side
effects and the emerging of resistance phenomena. Recently, a phosphine copper (I) …

In Vitro and in Vivo Anticancer Activity of Copper(I) Complexes with Homoscorpionate Tridentate Tris(pyrazolyl)borate and Auxiliary Monodentate Phosphine …

V Gandin, F Tisato, A Dolmella, M Pellei… - Journal of Medicinal …, 2014 - ACS Publications
Tetrahedral copper (I) TpCuP complexes 1–15, where Tp is a N, N, N-tris (azolyl) borate and
P is a tertiary phosphine, have been synthesized and characterized by means of NMR, ESI …